Case Challenges in nAMD and DME Management: Achieving Durable Response
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Click Here to Manage Email Alerts
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Activity Description
The management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with intravitreal anti-vascular endothelial growth factor (VEGF) therapies has provided enhanced visual outcomes for many patients. However, the high treatment burden associated with anti-VEGF therapies can lead to lack of patient adherence, resulting in suboptimal outcomes. Personalized treatment protocols using FDA-approved agents and newer novel delivery systems, along with agents with unique mechanisms of action, have been developed to address the treatment burden by extending the interval between dosing of treatment while providing visual acuity gains. In this case-based CE and COPE activity, experts in the field evaluate treatment protocols that offer increased efficacy, safety, and durability in patients with nAMD and DME and provide guidance for practices and procedures that can improve patient adherence to therapeutic regimens.
Target Audience
The intended audience for this activity is retina specialists, ophthalmologists, optometrists, and other healthcare professionals involved in the management of patients with nAMD and DME.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize treatment protocols that offer increased efficacy, safety, and durability in patients with nAMD and DME.
- Select the most appropriate treatment regimen in patients with nAMD and DME based on clinical presentation, imaging, and the latest evidence on efficacy and safety.
- Incorporate practices and procedures that can improve patient adherence to nAMD and DME therapeutic regimens.
Activity Chair
Carl J. Danzig, MD, FASRS
Director of Vitreoretinal Services and Retina Clinical Research
Rand Eye Institute
Deerfield Beach, FL
Affiliate Assistant Professor of Clinical Biomedical Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, FL
Faculty
Ferhina S. Ali, MD, MPH
Assistant Professor, New York Medical College
Valhalla, NY
Jordan M. Graff, MD, FACS, FABO
Surgeon & Partner, BDP Eye Center – Retina Division
American Vision Partners (AVP) Medical Executive Team
Phoenix, AZ
Michael A. Singer, MD
Director of Clinical Research
Medical Center Ophthalmology Associates
Clinical Professor of Ophthalmology
University of Texas Health Science Center
San Antonio, TX
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Walter O. Whitley, OD, MBA, FAAO
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity will also award credit for optometry (COPE) if the requirements necessary for credit are met.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education designates this enduring activity for a maximum of 1.25 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
COPE Course ID: 84876-TD
COPE Activity ID: 126217
This enduring material is approved for 1 year from the date of original release, May 31, 2023, to May 30, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or COPE CE Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Ferhina S. Ali, MD, MPH
Advisor: AbbVie/Allergan, Apellis, Genentech, Regeneron
Consultant: Apellis, Genentech, Regeneron
Speaker Contracted by Ineligible Company: Apellis
Carl J. Danzig, MD, FASRS
Consultant: AbbVie, Alimera, Genentech, Iveric Bio, Regeneron, Regenxbio, Roche
Speaker Contracted by Ineligible Company: Genentech
Independent Research Contractor: Curacle, Genentech, Gyroscope, Iveric Bio, Kodiak, Novartis, Regeneron, Regenxbio, Roche, Unity
Jordan M. Graff, MD, FACS, FABO
Consultant: Genentech/Roche
Speaker Contracted by Ineligible Company: Genentech/Roche
Independent Research Contractor: Genentech/Roche, Novartis, Regeneron, Regenxbio
Michael A. Singer, MD
Consultant: Adverum, Aerie, Alimera, Allergan, Bausch + Lomb, Biogen, EyePoint, Genentech, Novartis, Ocular Therapeutics, Regeneron
Speaker Contracted by Ineligible Company: Allergan, Apellis, Biogen, EyePoint, Genentech, Regeneron
Independent Research Contractor: Adverum, Aerie, Alimera, Allergan, Ashvattha, Clearside, DRCR, Genentech, Icon, Ionis, KalVista, Kodiak, Jansen, Novartis, OcuTerra, Opthea, Optos, Oyster Point, Regeneron, Recens, Rezolute, Ribomic, Santen, Senju, Sydnexis
Individual Stocks and Stock Options: Aciveda, Inflammasome, Nanoscope, Olive
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Walter O. Whitley, OD, MBA, FAAO
Consultant: Aerie, Alcon, Aldeyra, Allergan, Bausch + Lomb, Bruder, Dompé, Eyenovia, Heru, Iveric Bio, Kala, MediPrint, Oyster Point, Regener-Eyes, Santen, ScienceBased Health, Sight Sciences, Sun, Tarsus, Visus
Speaker Contracted by Ineligible Company: Aerie, Alcon, Allergan, Bausch + Lomb, Kala, Oyster Point, Santen, Sun
Individual Stocks and Stock Options: MediPrint
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this web activity is available upon request. Requests should include the web activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher.
The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com